Connect with us

Insight

All female-led CBD company to list on London Stock Exchange

It will be the first multi-brand CBD-focused consumer goods business to list on the LSE.

Published

on

South West Brands CEO Rebekah Hall (second right) leads the all-female management team

The multi-brand consumer goods company South West Brands has announced its intention to apply for listing on the London Stock Exchange (LSE).

South West Brands expects to be admitted to the LSE in July and will be the first multi-brand CBD-focused consumer goods business to list on the LSE.

The group develops, licences, and markets CBD brands to consumers across the UK.

It plans to raise equity to continue to develop its existing portfolio of brands and pursue its strategy of adding more assets over the next two years.

Launched earlier this year, the all-female management team brings together extensive experience from both the consumer products sector and the CBD industry, supported by an exemplary board with experience across brand building, marketing, licensing, finance, and cannabis.

Its CEO Rebekah Hall brings almost a decade of experience in investment banking to the role, and helped set up Botanic Lab, the company behind Europe’s first CBD drink in 2018.

Rebekah Hall, CEO comes from a background in investment banking

Hall commented: “This is a key moment in the development of the CBD industry. South West Brands is uniquely placed to take advantage of this growing market and the significant opportunity that exists in branded goods. The time is right to advance consumer products expertise, discipline, and structures that can elevate the industry and consumer experience, ultimately building world class brand assets that utilise CBD.

“Our listing on the London Stock Exchange will enable South West Brands to access the new pool of cannabis investors that has grown in London following the successful admission of a number of cannabis companies in 2021. The Admission will allow the Group to advance to the next stages of its growth plans, and build a suite of strong brands that not only utilise CBD, but drive consumer engagement and product sell-through, something which has been missing in the industry thus far.”

The company has identified key product areas and markets which it will look to build and develop quality CBD brands that address areas of underserved consumer need.

These include: Drinks, Menstrual cycle care, Generation Z Skincare, Sport, Men’s holistic wellness, Menopausal care and 50+ supplements.

As well as Botanic Lab, the South West Brands has two further brands in development that are expected to launch later in the year, including Love,MeMeMe a Generation Z focused beauty and wellness brand, and FEWE, a menstrual cycle care brand.

Sarah Sinclair is a respected cannabis journalist writing on subjects related to science, medicine, research, health and wellness. She is managing editor of Cannabis Health, the UK’s leading title covering medical cannabis and CBD, and sister title and Psychedelic Health. Sarah has an NCTJ journalism qualification and an MA in Journalism from the University of Sunderland. Sarah has over six years experience working on newspapers, magazines and digital-first titles, the last two of which have been in the cannabis sector. She has also completed training through the Medical Cannabis Clinicians Society securing a certificate in Medical Cannabis Explained. She is a member of PLEA’s (Patient-Led Engagement for Access) advisory board, has hosted several webinars on cannabis and women's health and has moderated at industry events such as Cannabis Europa. Sarah Sinclair is the editor of Cannabis Health. Got a story? Email sarah@prohibitionpartners.com / Follow us on Twitter: @CannabisHNews / Instagram: @cannabishealthmag

Trending

Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2024 PP Intelligence Ltd.